Results 151 to 160 of about 6,366 (207)

Dextroamphetamine

Archives of General Psychiatry, 1972
Nine informed volunteers having previous experience with self-administered drugs were given small, frequent orally administered doses of dextroamphetamine sulfate. Within five days following supervised administration, eight subjects experienced a paranoid psychosis which rapidly abated with drug discontinuance.
J D, Griffith, J, Cavanaugh, J, Held, J A, Oates   +3 more
exaly   +3 more sources

Dextroamphetamine-Sulfate-Induced Dyskinesias

JAMA - Journal of the American Medical Association, 1968
Dyskinesia developed in four patients soon after the administration of therapeutic doses of dextroamphetamine sulfate. The movements were tic-like, dystonic, and similar to those occasionally produced by phenothiazines, and they promptly disappeared when the use of the drug ceased. They probably represented idiosyncratic reactions rather than extension
R H, Mattson, J R, Calverley
exaly   +4 more sources

Methylphenidate, Dextroamphetamine, and Levamfetamine

Archives of General Psychiatry, 1976
Methylphenidate hydrochloride dextroamphetamine sulfate, and levamfetamine succinate have potential as pharmacologic tools for the indirect evaluation of the role of neurotransmitters in schizophrenia. In actively ill schizophrenic patients, methylphenidate administered intravenously causes a brief but clear intensification of preexisting psychotic ...
D S, Janowsky, J M, Davis
exaly   +3 more sources

Dextroamphetamine Poisoning

New England Journal of Medicine, 1962
exaly   +2 more sources

Dextroamphetamine-Morphine Analgesia

New England Journal of Medicine, 1977
exaly   +2 more sources

Adderall® (Amphetamine-Dextroamphetamine) Toxicity

Topics in Companion Animal Medicine, 2013
The American Psychiatric Association estimates that 3-7% of US school-aged children exhibit attention-deficit/hyperactivity disorder (ADHD). Adderall(®) (amphetamine dextroamphetamine) and a variety of brand names and generic versions of this combination are available by prescription to treat ADHD and narcolepsy.
Kevin T, Fitzgerald, Alvin C, Bronstein
openaire   +2 more sources

Transdermal Dextroamphetamine (Xelstrym) for ADHD

The Medical Letter on Drugs and Therapeutics, 2023
The FDA has approved a dextroamphetamine transdermal patch (Xelstrym – Noven) for once-daily treatment of attention-deficit/hyperactivity disorder (ADHD) in patients ≥6 years old. Xelstrym is the first transdermal amphetamine product to be approved in the US.
openaire   +2 more sources